e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acute exacerbation of ILD: an Indian tertiary centre experience
J. Mullerpattan (Mumbai, India), P. Sheth (Mumbai, India), A. Joshi (Mumbai, India), Z. Udwadia (Mumbai, India)
Source:
International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session:
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session type:
Thematic Poster
Number:
2980
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Mullerpattan (Mumbai, India), P. Sheth (Mumbai, India), A. Joshi (Mumbai, India), Z. Udwadia (Mumbai, India). Acute exacerbation of ILD: an Indian tertiary centre experience. 2980
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Costs of the patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease in a tertiary university hospital of Turkey
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Acute exacerbations of interstitial lung diseases:experience of 6 years from a portuguese hospital center
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
The impact of ethnicity on patients presenting with acute asthma exacerbation: The experiences of an inner city district general hospital
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Causes of severe recurrent respiratory symptoms in childhood: the experience of a tertiary reference centre for paediatric pulmonology
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001
Acute exacerbation of bronchiectasis – Experience of a Tunisian pulmonology department
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Cardiac sarcoidosis: a tertiary centre experience
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018
High frequency of anemia in severe acute COPD admitted in a tertiary hospital
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005
Paediatric necrotizing pneumonia: single tertiary center experience
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
The prevalence of bronchitis and associations with spirometry in patients with interstitial lungdisease in a Canadian tertiary care centre
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Sustaining a chronic obstructive pulmonary disease (COPD) discharge care bundle on the respiratory ward in an acute district general hospital
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres
Source: International Congress 2016 – IPF treatment II
Year: 2016
Significance of neutrophil to lymphocyte ratio in patients of chronic obstructive pulmonary diseases: A prospective study at tertiary care centre in India
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Survey of chronic cough in children at output patients department in a tertiary medical center in middle Taiwan
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010
Management of acute exacerbations of COPD (AECOPD); experience from a district general hospital in north west England
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012
Predictors of outcomes in COPD exacerbation cases presenting to the emergency department
Source: Eur Respir J 2008; 32: 953-961
Year: 2008
Interstitial lung disease at a district general hospital: When are patients referred to tertiary care?
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Prevalence and characteristics of venous thromboembolism in severe exacerbation of COPD in a tertiary care hospital in India
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Clinical differences between patients admitted to hospital with an acute or non-acute exacerbation of COPD
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Chest radiographs in acute pulmonary embolism: an experience at tertiary care center in Pakistan
Source: Eur Respir J 2005; 26: Suppl. 49, 316s
Year: 2005
Variability of hospital resources for acute care of COPD patients: the European COPD Audit
Source: Eur Respir J 2014; 43: 754-762
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept